Cancer care commercial reimbursement data and its uses: an expert interview with Alli Oakes, Trilliant Health

Alli Oakes, Chief Research Officer at Trilliant Health, sat down with HTN's Martin Cech on August 19, 2026 to discuss the wide variation in cancer-care price growth across US markets, why national inflation benchmarks like CPI and PPI fail to capture local pricing trends, and how employers and TPAs can use price transparency data to design smarter benefits and network strategies.